Table 1.
Drug Carriers | Drug Species | Release Pathways | Advantages | Reference |
---|---|---|---|---|
Poly(methacrylic acid)/poly(N-vinylpyrrolidone) multilayer hydrogel capsules |
Nucleic acids | Ultrasound-triggered release | Higher effective loading capacity and controlled delivery of sensitive biomolecules | [53] |
Poly(N-vinylcaprolactam) multilayer hydrogels | Sodium diclofenac | Increase in temperature | Multiple drug delivery | [54] |
Chitosan multilayer hydrogel capsules | Doxorubicin | Adjustment of pH | Significant inhibition of the burst release and good biocompatibility, | [55] |
Polycarboxymethyl-β-cyclodextrin (polyCM-β-CD)/polyetherimide (PEI) multilayer | Ofloxacin | Adjustment of pH | Controllable release in different media | [56] |
Poly(methacrylic acid) (PMAA) multilayer hydrogel cubes | 7-(benzylamino)-3,4-dihydro-pyrrolo[4,3,2-de]quinolin-8(1H)-one | Redox-triggered release | Long-term storage, combination of well-regulated drug release and shape-modulated drug delivery | [57] |